US abandons mRNA vaccine development despite triumphs
The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous, […]
The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous, […]
Provisions in the One Big, Beautiful Bill Act capping student loans will make it more difficult for medical students —
Individuals who adhere to the EAT-Lancet diet demonstrate a lower risk for rheumatoid arthritis, with metabolomic signatures suggesting specific metabolic
Pregnancy for women with lupus nephritis is considered high risk and requires multidisciplinary care involving maternal fetal medicine, nephrology, rheumatology
Puffy hands and fingers, as well as other symptoms, can precede the “warning sign” of Raynaud’s syndrome as the initial
In this video, Philip J. Mease, MD, director of rheumatology research at Providence Swedish Medical Center, in Seattle, discusses results
In this video, Philip J. Mease, MD, discusses results from phase 3 clinical trials of deucravacitinib for psoriatic arthritis, presented